Age, APOE and sex: Triad of risk of Alzheimer's disease

Journal of Steroid Biochemistry and Molecular Biology

Volumn 160, Issue , 2016, Pages 134-147

  Riedel, Brandalyn C ^a   Thompson, Paul M ^a   Brinton, Roberta Diaz ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Age; Alzheimer's disease; ApoE; Bioenergetics; Brain; Mitochondria; Sex difference

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; ESTROGEN; HORMONE; LIPOPROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4; CHOLESTEROL;

AGING; ALZHEIMER DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; CLIMACTERIUM; FEMALE; GENOTYPE; HORMONE ACTION; HUMAN; MALE; MENOPAUSE; MULTIINFARCT DEMENTIA; NONHUMAN; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; RISK FACTOR; SEX DIFFERENCE; ALLELE; ANIMAL; GENETICS; HOMOZYGOTE; METABOLISM; MOLECULAR MODEL; PATHOLOGY; SEX FACTOR;

AGING; ALLELES; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEIN E4; CHOLESTEROL; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MENOPAUSE; MODELS, MOLECULAR; RISK FACTORS; SEX FACTORS;

EID: 84962088949     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2016.03.012     Document Type: Review

References (178)

1. R. Brookmeyer, S. Gray, and C. Kawas Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset Am. J. Public Health 88 1998 1337 1342
2. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, and H.M. Arrighi Forecasting the global burden of Alzheimer's disease Alzheimers Dement 3 2007 186 191
3. L.E. Hebert, J. Weuve, P.A. Scherr, and D.A. Evans Alzheimer disease in the United States (2010-2050) estimated using the 2010 census Neurology 80 2013 1778 1783
4. R. Mayeux, Y. Stern, R. Ottman, T.K. Tatemichi, M.X. Tang, G. Maestre, C. Ngai, B. Tycko, and H. Ginsberg The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease Ann. Neurol. 34 1993 752 754
5. R.W. Mahley, K.H. Weisgraber, and Y. Huang Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS J. Lipid Res. 50 suppl 2009 S183 188
6. C.C. Liu, T. Kanekiyo, H. Xu, and G. Bu Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy Nat. Rev. Neurol. 9 2013 106 118
7. H. Payami, K.R. Montee, J.A. Kaye, T.D. Bird, C.-E. Yu, E.M. Wijsman, and G.D. Schellenberg Alzheimer's disease, apolipoprotein E4, and gender JAMA 271 1994 1316 1317
8. L.A. Farrer, L.A. Cupples, J.L. Haines, B. Hyman, W.A. Kukull, R. Mayeux, R.H. Myers, M.A. Pericak-Vance, N. Risch, and C.M. van Duijn Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis JAMA 278 1997 1349 1356
9. E.L. Mortensen, and P. Hogh A gender difference in the association between APOE genotype and age-related cognitive decline Neurology 57 2001 89 95
10. J.S. Damoiseaux, W.W. Seeley, J. Zhou, W.R. Shirer, G. Coppola, A. Karydas, H.J. Rosen, B.L. Miller, J.H. Kramer, and M.D. Greicius Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels J. Neurosci. 32 2012 8254 8262
11. L.L. Barnes, R.S. Wilson, J.A. Schneider, J.L. Bienias, D.A. Evans, and D.A. Bennett Gender, cognitive decline, and risk of AD in older persons Neurology 60 2003 1777 1781
12. R. Miech, J. Breitner, P. Zandi, A. Khachaturian, J. Anthony, and L. Mayer Incidence of AD may decline in the early 90s for men, later for women the Cache County Study Neurology 58 2002 209 218
13. A. Ruitenberg, A. Ott, J.C. van Swieten, A. Hofman, and M.M. Breteler Incidence of dementia: does gender make a difference? Neurobiol. Aging 22 2001 575 580
14. National Institute on Aging 2015 Alzheimer's Disease Progress Report 2014-2015: Advancing Research Toward a Cure. Bethesda: National Institute on Aging, National Institute of Health, US Department of Health and Human Services.
15. United Nations DoEaSAPD 2001 World Population Ageing: 1950-2050. New York: United Nations.
16. United Nations DoEaSAPD World Population Ageing 2015. In. 5th ed. New York: United Nations.
17. C.L. Masters, R. Bateman, K. blennow, C.C. Rowe, R.A. Sperling, and J.L. Cummings Alzheimer's Disease 2015 Nature Reviews Disease Primers 15059
18. R.D. Brinton, J. Yao, F. Yin, W.J. Mack, and E. Cadenas Perimenopause as a neurological transition state Nat. Rev. Endocrinol. 11 2015 393 405
19. S.S. Petanceska Age-associated androgen deficiency and Alzheimer's disease: a case in the making? J. Alzheimers Dis. 5 2003 271 273
20. E.M. Blalock, K.C. Chen, K. Sharrow, J.P. Herman, N.M. Porter, T.C. Foster, and P.W. Landfield Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment J. Neurosci. 23 2003 3807 3819
21. E.M. Blalock, H.M. Buechel, J. Popovic, J.W. Geddes, and P.W. Landfield Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease J. Chem. Neuroanat. 42 2011 118 126
22. E.M. Blalock, J.W. Geddes, K.C. Chen, N.M. Porter, W.R. Markesbery, and P.W. Landfield Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses Proc. Natl. Acad. Sci. U. S. A. 101 2004 2173 2178
23. R.D. Brinton Neurosteroids as regenerative agents in the brain: therapeutic implications Nat. Rev. Endocrinol. 9 2013 241 250
24. H.M. Chow, and K. Herrup Genomic integrity and the ageing brain Nat. Rev. Neurosci. 16 2015 672 684
25. R. Curtis, B.J. Geesaman, and P.S. DiStefano Ageing and metabolism: drug discovery opportunities Nat. Rev. Drug Discov. 4 2005 569 580
26. K. Dorshkind, E. Montecino-Rodriguez, and R.A. Signer The ageing immune system: is it ever too old to become young again? Nat. Rev. Immunol. 9 2009 57 62
27. A.C. Shaw, D.R. Goldstein, and R.R. Montgomery Age-dependent dysregulation of innate immunity Nat. Rev. Immunol. 13 2013 875 887
28. M. Yeoman, G. Scutt, and R. Faragher Insights into CNS ageing from animal models of senescence Nat. Rev. Neurosci. 13 2012 435 445
29. F. Yin, J. Yao, H. Sancheti, T. Feng, R.C. Melcangi, T.E. Morgan, C.E. Finch, C.J. Pike, W.J. Mack, E. Cadenas, and R.D. Brinton The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity Neurobiol. Aging 36 2015 2282 2295
30. L.P. Klosinski, J. Yao, F. Yin, A.N. Fonteh, M.G. Harrington, T.A. Christensen, E. Trushina, and R.D. Brinton White matter lipids as a ketogenic fuel supply in aging female brain: implications for Alzheimer's disease EBioMedicine 2 2015 1888 1904
31. L. Puglielli, R.E. Tanzi, and D.M. Kovacs Alzheimer's disease: the cholesterol connection Nat. Neurosci. 6 2003 345 351
32. J.R. Rettberg, H. Dang, H.N. Hodis, V.W. Henderson, J.A. St John, W.J. Mack, and R.D. Brinton Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype Neurobiol. Aging 40 2016 155 163
33. P. Holmans, M. Hamshere, P. Hollingworth, F. Rice, N. Tunstall, S. Jones, P. Moore, F. Wavrant DeVrieze, A. Myers, R. Crook, D. Compton, H. Marshall, D. Meyer, S. Shears, J. Booth, D. Ramic, N. Williams, N. Norton, R. Abraham, P. Kehoe, H. Williams, V. Rudrasingham, M. O'Donovan, L. Jones, J. Hardy, A. Goate, S. Lovestone, M. Owen, and J. Williams Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease Am. J. Med. Genet. B Neuropsychiatr. Genet. 135B 2005 24 32
34. J.M. Wang, R.W. Irwin, and R.D. Brinton Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo Proc. Natl. Acad. Sci. U. S. A. 103 2006 16983 16988
35. G. Bu Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Nat. Rev. Neurosci. 10 2009 333 344
36. V. Leduc, S. Jasmin-Belanger, and J. Poirier APOE and cholesterol homeostasis in Alzheimer's disease Trends Mol. Med. 16 2010 469 477
37. D.M. Lyall, S.E. Harris, M.E. Bastin, S. Munoz Maniega, C. Murray, M.W. Lutz, A.M. Saunders, A.D. Roses, C. Valdes Hernandez Mdel, N.A. Royle, J.M. Starr, D.J. Porteous, J.M. Wardlaw, and I.J. Deary Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936 Neurobiol. Aging 35 1513 2014 e1525 1533
38. C.S. Hanlon, and D.C. Rubinsztein Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans Atherosclerosis 112 1995 85 90
39. R. Corbo, and R. Scacchi Apolipoprotein E (APOE) allele distribution in the world. is APOE∗4 a 'thrifty'allele? Ann. Hum. Genet. 63 1999 301 310
40. L.H. Kuller, L. Shemanski, T. Manolio, M. Haan, L. Fried, N. Bryan, G.L. Burke, R. Tracy, and R. Bhadelia Relationship between ApoE, MRI findings, and cognitive function in the cardiovascular health study Stroke 29 1998 388 398
41. Y.R. Su, J.L. Blakemore, Y. Zhang, M.F. Linton, and S. Fazio Lentiviral transduction of ApoAI into hematopoietic progenitor cells and macrophages applications to cell therapy of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 28 2008 1439 1446
42. M. Miyata, and J.D. Smith Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides Nat. Genet. 14 1996 55 61
43. N. Zhong, and K.H. Weisgraber Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure J. Biol. Chem. 284 2009 6027 6031
44. R.Y. Huang, K. Garai, C. Frieden, and M.L. Gross Hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry determine the interface and dynamics of apolipoprotein E oligomerization Biochemistry 50 2011 9273 9282
45. J. Louhija, H.E. Miettinen, K. Kontula, M.J. Tikkanen, T. Miettinen, and R. Tilvis Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians Arterioscler. Thromb. Vasc. Biol. 14 1994 1084 1089
46. R.W. Mahley, and S.C. Rall Jr. Apolipoprotein E: far more than a lipid transport protein Annu. Rev. Genomics Hum. Genet. 1 2000 507 537
47. N.A. Elshourbagy, W.S. Liao, R.W. Mahley, and J.M. Taylor Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets Proc. Natl. Acad. Sci. 82 1985 203 207
48. Q. Xu, A. Bernardo, D. Walker, T. Kanegawa, R.W. Mahley, and Y. Huang Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus J. Neurosci. 26 2006 4985 4994
49. F. Schiele, D. De Bacquer, M. Vincent-Viry, U. Beisiegel, C. Ehnholm, A. Evans, A. Kafatos, M. Martins, S. Sans, and C. Sass Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project Atherosclerosis 152 2000 475 488
50. A. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. CrapperMacLachlan, M.J. Alberts, C.M. Hulette, B.J. Crain, D. Goldgaber, and A.D. Roses Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease Neurology 43 1993 1467 1472
51. S. Reilly, R. Ferrell, B. Kottke, and C. Sing The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota II. Regression relationships with concomitants Am. J. Hum. Genet. 51 1992 1311
52. R.E. Gregg, L.A. Zech, E.J. Schaefer, and H.B. Brewer Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E Science 211 1981 584 586
53. J.E. Vance, and H. Hayashi Formation and function of apolipoprotein E-containing lipoproteins in the nervous system Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids 1801 2010 806 818
54. K.L. Rasmussen, A. Tybjærg-Hansen, B.G. Nordestgaard, and R. Frikke-Schmidt Plasma levels of apolipoprotein E and risk of dementia in the general population Ann. Neurol. 77 2015 301 311
55. J.-S. Gong, M. Kobayashi, H. Hayashi, K. Zou, N. Sawamura, S.C. Fujita, K. Yanagisawa, and M. Michikawa Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice J. Biol. Chem. 277 2002 29919 29926
56. G. Chêne, A. Beiser, R. Au, S.R. Preis, P.A. Wolf, C. Dufouil, and S. Seshadri Gender and incidence of dementia in the Framingham Heart Study from mid-adult life Alzheimer's Dement. 11 2015 310 320
57. R.M. Lane, and M.R. Farlow Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease J. Lipid Res. 46 2005 949 968
58. E.C. Leigh-Firbank, A.M. Minihane, D.S. Leake, J.W. Wright, M.C. Murphy, B.A. Griffin, and C.M. Williams Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses Br. J. Nutr. 87 2002 435 445
59. J.M. Ordovas, and E.J. Schaefer Genes, variation of cholesterol and fat intake and serum lipids Curr. Opin. Lipidol. 10 1999 15 22
60. H.M. Dashti, T.C. Mathew, T. Hussein, S.K. Asfar, A. Behbahani, M.A. Khoursheed, H.M. Al-Sayer, Y.Y. Bo-Abbas, and N.S. Al-Zaid Long-term effects of a ketogenic diet in obese patients Exp. Clin. Cardiol. 9 2004 200
61. M.J. Sharman, W.J. Kraemer, D.M. Love, N.G. Avery, A.L. Gómez, T.P. Scheett, and J.S. Volek A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men J. Nutr. 132 2002 1879 1885
62. S. Cunnane, S. Nugent, M. Roy, A. Courchesne-Loyer, E. Croteau, S. Tremblay, A. Castellano, F. Pifferi, C. Bocti, and N. Paquet Brain fuel metabolism, aging, and Alzheimer's disease Nutrition 27 2011 3 20
63. R.J. Wood, J.S. Volek, Y. Liu, N.S. Shachter, J.H. Contois, and M.L. Fernandez Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men J. Nutr. 136 2006 384 389
64. W.S. Yancy, M.K. Olsen, J.R. Guyton, R.P. Bakst, and E.C. Westman A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial Ann. Intern. Med. 140 2004 769 777
65. A. Mente, L. de Koning, H.S. Shannon, and S.S. Anand A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease Arch. Intern. Med. 169 2009 659 669
66. C. Lahoz, E.J. Schaefer, L.A. Cupples, P.W. Wilson, D. Levy, D. Osgood, S. Parpos, J. Pedro-Botet, J.A. Daly, and J.M. Ordovas Apolipoprotein E genotype and cardiovascular disease in the Framingham heart study Atherosclerosis 154 2001 529 537
67. K. Wallenfeldt, L. Bokemark, J. Wikstrand, J. Hulthe, and B. Fagerberg Apolipoprotein B/apolipoprotein AI in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men Stroke 35 2004 2248 2252
68. I. Shalaurova, M.A. Connelly, W.T. Garvey, and J.D. Otvos Lipoprotein insulin resistance index: a lipoprotein Particle-Derived measure of insulin resistance Metabolic Syndrome Relat. Disord. 12 2014 422 429
69. E. Olano-Martin, E. Anil, M.J. Caslake, C.J. Packard, D. Bedford, G. Stewart, D. Peiris, C.M. Williams, and A.M. Minihane Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil Atherosclerosis 209 2010 104 110
70. J. Chen, Q. Li, and J. Wang Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions Proc. Natl. Acad. Sci. 108 2011 14813 14818
71. R.W. Mahley, K.H. Weisgraber, and Y. Huang Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease Proc. Natl. Acad. Sci. 103 2006 5644 5651
72. P.E. Cramer, J.R. Cirrito, D.W. Wesson, C.D. Lee, J.C. Karlo, A.E. Zinn, B.T. Casali, J.L. Restivo, W.D. Goebel, and M.J. James ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models Science 335 2012 1503 1506
73. S. Lee, Y.S. Lee, S.H. Jung, S.S. Kang, and K.H. Shin Anti-oxidant activities of Fucosterol from the marine Algaepelvetia Siliquosa Arch. Pharmacal Res. 26 2003 719 722
74. A. Roses, M. Lutz, H. Amrine-Madsen, A. Saunders, D. Crenshaw, S. Sundseth, M. Huentelman, K. Welsh-Bohmer, and E. Reiman A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease Pharm. J. 10 2010 375 384
75. H. Soares, W. Potter, E. Pickering, M. Kuhn, F. Immermann, D. Shera, M. Ferm, R. Dean, A. Simon, and F. Swenson Biomarkers consortium Alzheimer's disease plasma proteomics project. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease Arch. Neurol. 69 2012 1310 1317
76. N. Shachter, T. Hayek, T. Leff, J. Smith, D. Rosenberg, A. Walsh, R. Ramakrishnan, I. Goldberg, H. Ginsberg, and J. Breslow Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice J. Clin. Invest. 93 1994 1683
77. R.P. Middelberg, M.A. Ferreira, A.K. Henders, A.C. Heath, P.A. Madden, G.W. Montgomery, N.G. Martin, and J.B. Whitfield Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits BMC Med. Genet. 12 2011 123
78. L.A. Medeiros, T. Khan, J.B. El Khoury, C.L. Pham, D.M. Hatters, G.J. Howlett, R. Lopez, K.D. O'Brien, and K.J. Moore Fibrillar amyloid protein present in atheroma activates CD36 signal transduction J. Biol. Chem. 279 2004 10643 10648
79. J. Serra-Grabulosa, P. Salgado-Pineda, C. Junqué, C. Sole-Padulles, P. Moral, A. López-Alomar, T. Lopez, A. Lopez-Guillen, N. Bargallo, and J. Mercader Apolipoproteins E and C1 and brain morphology in memory impaired elders Neurogenetics 4 2003 141 146
80. K. Garai, B. Baban, and C. Frieden Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles Biochemistry 50 2011 2550 2558
81. M.J. LaDu, G.W. Munson, L. Jungbauer, G.S. Getz, C.A. Reardon, L.M. Tai, and C. Yu Preferential interactions between ApoE-containing lipoproteins and Abeta revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift Biochim. Biophys. Acta 1821 2012 295 302
82. A.M. Manelli, W.B. Stine, L.J. Van Eldik, and M.J. LaDu ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function J. Mol. Neurosci. 23 2004 235 246
83. M.J. LaDu, T.M. Pederson, D.E. Frail, C.A. Reardon, G.S. Getz, and M.T. Falduto Purification of Apolipoprotein E attenuates isoform-specific binding to-amyloid J. Biol. Chem. 270 1995 9039 9042
84. R.D. Bell, E.A. Winkler, I. Singh, A.P. Sagare, R. Deane, Z. Wu, D.M. Holtzman, C. Betsholtz, A. Armulik, and J. Sallstrom Apolipoprotein E controls cerebrovascular integrity via cyclophilin A Nature 485 2012 512 516
85. A. Hafezi-Moghadam, K.L. Thomas, and D.D. Wagner ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage Am. J. Physiol.-Cell Physiol. 292 2007 C1256 C1262
86. E.M. Reiman, K. Chen, X. Liu, D. Bandy, M. Yu, W. Lee, N. Ayutyanont, J. Keppler, S.A. Reeder, and J.B. Langbaum Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease Proc. Natl. Acad. Sci. 106 2009 6820 6825
87. V.L. Villemagne, K.E. Pike, G. Chetelat, K.A. Ellis, R.S. Mulligan, P. Bourgeat, U. Ackermann, G. Jones, C. Szoeke, and O. Salvado Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease Ann. Neurol. 69 2011 181 192
88. L.G. Apostolova, K.S. Hwang, O. Kohannim, D. Avila, D. Elashoff, C.R. Jack, L. Shaw, J.Q. Trojanowski, M.W. Weiner, and P.M. Thompson ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease NeuroImage Clin. 4 2014 461 472
89. R.E. Bennett, T.J. Esparza, H.A. Lewis, E. Kim, C.L. Mac Donald, P.M. Sullivan, and D.L. Brody Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice J. Neuropathol. Exp. Neurol. 72 2013 396 403
90. W. Strittmatter, K. Weisgraber, M. Goedert, A. Saunders, D. Huang, E. Corder, L. Dong, R. Jakes, M. Alberts, and J. Gilbert Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype Exp. Neurol. 125 2 1994 163 171
91. N. Mattsson, H. Zetterberg, O. Hansson, N. Andreasen, L. Parnetti, M. Jonsson, S.-K. Herukka, W.M. van der Flier, M.A. Blankenstein, and M. Ewers CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment JAMA 302 2009 385 393
92. Y. Ohno-Iwashita, Y. Shimada, A.A. Waheed, M. Hayashi, M. Inomata, M. Nakamura, M. Maruya, and S. Iwashita Perfringolysin O, a cholesterol-binding cytolysin, as a probe for lipid rafts Anaerobe 10 2004 125 134
93. F.M. Harris, W.J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss-Coray, J.D. Fish, E. Masliah, P.C. Hopkins, and K. Scearce-Levie Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice Proc. Natl. Acad. Sci. 100 2003 10966 10971
94. W.J. Brecht, F.M. Harris, S. Chang, I. Tesseur, G.-Q. Yu, Q. Xu, J.D. Fish, T. Wyss-Coray, M. Buttini, and L. Mucke Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice J. Neurosci. 24 2004 2527 2534
95. S. Chang, T. ran Ma, R.D. Miranda, M.E. Balestra, R.W. Mahley, and Y. Huang Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity Proc. Natl. Acad. Sci. U. S. A. 102 2005 18694 18699
96. C. Conejero-Goldberg, T. Hyde, S. Chen, U. Dreses-Werringloer, M. Herman, J. Kleinman, P. Davies, and T. Goldberg Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype Mol. Psychiatry 16 2011 836 847
97. F. Crivello, H. Lemaître, C. Dufouil, B. Grassiot, N. Delcroix, N. Tzourio-Mazoyer, C. Tzourio, and B. Mazoyer Effects of ApoE-î4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons Neuroimage 53 2010 1064 1069
98. Y. Ihara, T. Hayabara, K. Sasaki, R. Kawada, Y. Nakashima, and S. Kuroda Relationship between oxidative stress and apoE phenotype in Alzheimer's disease Acta Neurol. Scand. 102 2000 346 349
99. B. Gau, K. Garai, C. Frieden, and M.L. Gross Mass spectrometry-based protein footprinting characterizes the structures of oligomeric apolipoprotein E2, E3, and E4 Biochemistry 50 2011 8117 8126
100. C. Ramassamy, D. Averill, U. Beffert, S. Bastianetto, L. Theroux, S. Lussier-Cacan, J.S. Cohn, Y. Christen, J. Davignon, and R. Quirion Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype Free Radic. Biol. Med. 27 1999 544 553
101. J. Chen, Q. Li, and J. Wang Topology of human apolipoprotein e3 uniquely regulates its diverse biological functions Proc. Natl. Acad. Sci. 108 2011 14813 14818
102. G. Jarvik, E.M. Wijsman, W. Kukull, G. Schellenberg, C. Yu, and E. Larson Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease a case-control study Neurology 45 1995 1092 1096
103. J. Raber, Y. Huang, and J.W. Ashford ApoE genotype accounts for the vast majority of AD risk and AD pathology Neurobiol. Aging 25 2004 641 650
104. S. Noguchi, K. Murakami, N. Yamada, H. Payami, J. Kaye, L. Heston, T. Bird, and G. Schellenberg Apolipoprotein E genotype and alzheimer's disease Lancet 342 1993 737 738
105. K.D. Coon, A.J. Myers, D.W. Craig, J.A. Webster, J.V. Pearson, D.H. Lince, V.L. Zismann, T.G. Beach, D. Leung, and L. Bryden A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease J. Clin. Psychiatry 68 2007 613
106. E. Corder, A. Saunders, W. Strittmatter, D. Schmechel, P. Gaskell, G. Small, A. Roses, J. Haines, and M.A. Pericak-Vance Gene Dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
107. C.R. Mondadori, J.-F. Dominique, A. Buchmann, H. Mustovic, M.A. Wollmer, C.F. Schmidt, P. Boesiger, C. Hock, R.M. Nitsch, and A. Papassotiropoulos Better memory and neural efficiency in young apolipoprotein E ϵ4 carriers Cereb. Cortex 17 2007 1934 1947
108. N.L. Marchant, S.L. King, N. Tabet, and J.M. Rusted Positive effects of cholinergic stimulation favor young APOE ϵ4 carriers Neuropsychopharmacology 35 2010 1090 1096
109. S. Evans, N.G. Dowell, N. Tabet, P.S. Tofts, S.L. King, and J.M. Rusted Cognitive and neural signatures of the APOE E4 allele in mid-aged adults Neurobiol. Aging 35 2014 1615 1623
110. S.Y. Bookheimer, M.H. Strojwas, M.S. Cohen, A.M. Saunders, M.A. Pericak-Vance, J.C. Mazziotta, and G.W. Small Patterns of brain activation in people at risk for Alzheimer's disease New Engl. J. Med. 343 2000 450 456
111. C. Smith, A. Andersen, R. Kryscio, F. Schmitt, M. Kindy, L. Blonder, and M. Avison Women at risk for AD show increased parietal activation during a fluency task Neurology 58 2002 1197 1202
112. J. Sheffler, J. Moxley, and N. Sachs-Ericsson Stress, race, and APOE: understanding the interplay of risk factors for changes in cognitive functioning Aging Mental Health 18 2014 784 791
113. P. Shaw, J.P. Lerch, J.C. Pruessner, K.N. Taylor, A.B. Rose, D. Greenstein, L. Clasen, A. Evans, J.L. Rapoport, and J.N. Giedd Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study Lancet Neurol. 6 2007 494 500
114. S. Moffat, C. Szekely, A. Zonderman, N. Kabani, and S. Resnick Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype Neurology 55 2000 134 136
115. G. Bartzokis, P.H. Lu, D.H. Geschwind, K. Tingus, D. Huang, M.F. Mendez, N. Edwards, and J. Mintz Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia Biol. Psychiatry 62 2007 1380 1387
116. Y.I. Sheline, J.C. Morris, A.Z. Snyder, J.L. Price, Z. Yan, G. D'Angelo, C. Liu, S. Dixit, T. Benzinger, and A. Fagan APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42 J. Neurosci. 30 2010 17035 17040
117. E.M. Reiman, K. Chen, G.E. Alexander, R.J. Caselli, D. Bandy, D. Osborne, A.M. Saunders, and J. Hardy Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc. Natl. Acad. Sci. 101 2004 284 289
118. E.M. Reiman, K. Chen, G.E. Alexander, R.J. Caselli, D. Bandy, D. Osborne, A.M. Saunders, and J. Hardy Correlations between apolipoprotein E ϵ4 gene Dose and brain-imaging measurements of regional hypometabolism Proc. Natl. Acad. Sci. U. S. A. 102 2005 8299 8302
119. L. Mosconi, D. Perani, S. Sorbi, K. Herholz, B. Nacmias, V. Holthoff, E. Salmon, J.C. Baron, M.T. De Cristofaro, A. Padovani, B. Borroni, M. Franceschi, L. Bracco, and A. Pupi MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET Neurology 63 2004 2332 2340
120. G. Chiang, W. Zhan, N. Schuff, and M. Weiner White matter alterations in cognitively normal apoE ϵ2Carriers: insight into alzheimer resistance? Am. J. Neuroradiol. 33 2012 1392 1397
121. D.M. Holtzman, J. Herz, and G. Bu 2012 Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease Cold Spring Harbor Perspect. Med. 2 2016 a006312
122. M. Prince, A. Wimo, M. Guerchet, G. Ali, Y. Wu, M. Prina, World Alzheimer Report, 2015. The Global Impact of Dementia: an analysis of prevalence, incidence, cost and trends. London.
123. A. Altmann, L. Tian, V.W. Henderson, and M.D. Greicius Sex modifies the APOE-related risk of developing Alzheimer disease Ann. Neurol. 75 2014 563 573
124. L.L. Barnes, R.S. Wilson, J.L. Bienias, J.A. Schneider, D.A. Evans, and D.A. Bennett Sex differences in the clinical manifestations of Alzheimer disease pathology Arch. Gen. Psychiatry 62 2005 685 691
125. K.A. Lin, K.R. Choudhury, B.G. Rathakrishnan, D.M. Marks, J.R. Petrella, and P.M. Doraiswamy Marked gender differences in progression of mild cognitive impairment over 8 years Alzheimers Dement (N. Y.) 1 2015 103 110
126. E. Corder, A. Saunders, W. Strittmatter, D. Schmechel, P. Gaskell, J. Rimmler, P. Locke, P. Conneally, K. Schmader, and R. Tanzi Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease Neurology 45 1995 1323 1328
127. E.M. Reiman, R.J. Caselli, L.S. Yun, K. Chen, D. Bandy, S. Minoshima, S.N. Thibodeau, and D. Osborne Preclinical evidence of Alzheimer's disease in persons homozygous for the ϵ4 allele for apolipoprotein E New Engl. J. Med. 334 1996 752 758
128. A. Fleisher, M. Grundman, C.R. Jack, R.C. Petersen, C. Taylor, H.T. Kim, D.H. Schiller, V. Bagwell, D. Sencakova, and M.F. Weiner Sex, apolipoprotein E ϵ4 status, and hippocampal volume in mild cognitive impairment Arch. Neurol. 62 2005 953 957
129. C.R. Jack, H.J. Wiste, S.D. Weigand, D.S. Knopman, P. Vemuri, M.M. Mielke, V. Lowe, M.L. Senjem, J.L. Gunter, and M.M. Machulda Age, sex, and APOE ϵ4 effects on memory, brain structure, and β-Amyloid across the adult life span JAMA Neurol. 72 2015 511 519
130. E.H. Corder, E. Ghebremedhin, M.G. Taylor, D.R. Thal, T.G. Orm, and H. Braak The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism Ann. N. Y. Acad. Sci. 1019 2004 24 28
131. K. Yaffe, M. Haan, A. Byers, C. Tangen, and L. Kuller Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction Neurology 54 2000 1949 1954
132. P. Newhouse, K. Albert, R. Astur, J. Johnson, M. Naylor, and J. Dumas Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women Neuropsychopharmacology 38 2013 2632 2643
133. F. Ding, J. Yao, J.R. Rettberg, S. Chen, and R.D. Brinton 2013 Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention PLoS One 8 2016 e79977
134. J.R. Rettberg, J. Yao, and R.D. Brinton Estrogen: a master regulator of bioenergetic systems in the brain and body Front. Neuroendocrinol. 35 2014 8 30
135. F. Ding, J. Yao, L. Zhao, Z. Mao, and S. Chen Brinton RD 2013 Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's PLoS One 8 2016 e59825
136. J. Yao, and R.D. Brinton Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease Adv. Pharmacol. 64 2012 327 371
137. J. Yao, J.R. Rettberg, L.P. Klosinski, E. Cadenas, and R.D. Brinton Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Mol. Aspects Med. 32 2011 247 257
138. J. Yao, R. Irwin, S. Chen, R. Hamilton, E. Cadenas, and R.D. Brinton Ovarian hormone loss induces bioenergetic deficits and mitochondrial beta-amyloid Neurobiol. Aging 33 2012 1507 1521
139. J. Yao, R.T. Hamilton, E. Cadenas, and R.D. Brinton Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence Biochim. Biophys. Acta 1800 2010 1121 1126
140. J. Yao, R.W. Irwin, L. Zhao, J. Nilsen, R.T. Hamilton, and R.D. Brinton Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 106 2009 14670 14675
141. J.B. Langbaum, K. Chen, R.J. Caselli, W. Lee, C. Reschke, D. Bandy, G.E. Alexander, C.M. Burns, A.W. Kaszniak, S.A. Reeder, J.J. Corneveaux, A.N. Allen, J. Pruzin, M.J. Huentelman, A.S. Fleisher, and E.M. Reiman Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele Arch. Neurol. 67 2010 462 468
142. J. Ryan, I. Carriere, L. Carcaillon, J.-F. Dartigues, S. Auriacombe, O. Rouaud, C. Berr, K. Ritchie, P.-Y. Scarabin, and M.-L. Ancelin Estrogen receptor polymorphisms and incident dementia: the prospective 3C study Alzheimers Dementia 10 2014 27 35
143. M. Darabi, M. Ani, M. Panjehpour, M. Rabbani, A. Movahedian, and E. Zarean Effect of estrogen receptor β A1730 G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy Genet. Test. Mol. Biomarkers 15 2011 11 15
144. R.A.K. Srivastava Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen Mol. Cell. Biochem. 240 2002 67 73
145. E.G. Jacobs, C. Kroenke, J. Lin, E.S. Epel, H.A. Kenna, E.H. Blackburn, and N.L. Rasgon Accelerated cell aging in female APOE-epsilon4 carriers: implications for hormone therapy use PLoS One 8 2013 e54713
146. R.W. Irwin, J. Yao, J. To, R.T. Hamilton, E. Cadenas, and R.D. Brinton Selective oestrogen receptor modulators differentially potentiate brain mitochondrial function J. Neuroendocrinol. 24 1 2012 236 248
147. K. Gabriel, B. Egan, and T. Lithgow Tom40, the import channel of the mitochondrial outer membrane, plays an active role in sorting imported proteins EMBO J. 22 2003 2380 2386
148. R.A.K. Srivastava, N. Srivastava, M. Averna, R.C. Lin, K.S. Korach, D.B. Lubahn, and G. Schonfeld Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor α-mediated pathway J. Biol. Chem. 272 1997 33360 33366
149. X. Cheng, M.E. McAsey, M. Li, S. Randall, C. Cady, B.P. Nathan, and R.G. Struble Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain Neurosci. Lett. 417 2007 50 54
150. M.M. Ivanova, B.N. Radde, J. Son, F.F. Mehta, S.-H. Chung, and C.M. Klinge Estradiol and tamoxifen regulate NRF-1 and mitochondrial function in mouse mammary gland and uterus J. Mol. Endocrinol. 51 2013 233 246
151. R.G. Struble, C. Cady, B.P. Nathan, and M. McAsey Apolipoprotein E may be a critical factor in hormone therapy neuroprotection Front. Biosci.: J. Virtual Libr. 13 2007 5387 5405
152. B.P. Nathan, A.G. Barsukova, F. Shen, M. McAsey, and R.G. Struble Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons Endocrinology 145 2004 3065 3073
153. D.C. Dean, B.A. Jerskey, K. Chen, H. Protas, P. Thiyyagura, A. Roontiva, J. O'Muircheartaigh, H. Dirks, N. Waskiewicz, and K. Lehman Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study JAMA Neurol. 71 2014 11 22
154. G. Bartzokis, P.H. Lu, D.H. Geschwind, N. Edwards, J. Mintz, and J.L. Cummings Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia Arch. Gen. Psychiatry 63 2006 63 72
155. M. Vincent-Viry, F. Schiele, R. Gueguen, K. Bohnet, S. Visvikis, and G. Siest Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study Clin. Chem. 44 1998 957 965
156. P.A. Lee, S.S. Guo, and H.E. Kulin Age of puberty: data from the United States of America APMIS 109 2001 S156 S163
157. H.G. Burger, E.C. Dudley, D.M. Robertson, and L. Dennerstein Hormonal changes in the menopause transition Recent Prog. Horm. Res. 57 2002 257 276
158. R. Li, J. Cui, and Y. Shen Brain sex matters: estrogen in cognition and Alzheimer's disease Mol. Cell. Endocrinol. 389 2014 13 21
159. N. Santoro, and K. Sutton-Tyrrell The SWAN song: study of women's health across the nation's recurring themes Obstet. Gynecol. Clin. North Am. 38 2011 417 423
160. N. Garatachea, E. Emanuele, M. Calero, N. Fuku, Y. Arai, Y. Abe, H. Murakami, M. Miyachi, T. Yvert, and Z. Verde ApoE gene and exceptional longevity: insights from three independent cohorts Exp. Gerontol. 53 2014 16 23
161. T. Asada, T. Kariya, Z. Yamagata, T. Kinoshita, and A. Asaka Apolipoprotein E allele in centenarians Neurology 46 1996 1484-1484
162. H. Blanché, L. Cabanne, M. Sahbatou, and G. Thomas A study of French centenarians: are ACE and APOE associated with longevity? Comptes Rendus de l'Académie des Sciences-Series III-Sciences de la Vie 324 2001 129 135
163. E. Castro, C.E. Ogburn, K.E. Hunt, R. Tilvis, J. Louhija, R. Penttinen, R. Erkkola, A. Panduro, R. Riestra, and C. Piussan Polymorphisms at the Werner locus: i Newly identified polymorphisms, ethnic variability of 1367Cy/Arg, and its stability in a population of Finnish centenarians Am. J. Med. Genet. 82 1999 399 403
164. F. Schachter, L. Faure-Delanef, F. Guénot, H. Rouger, P. Froguel, L. Lesueur-Ginot, and D. Cohen Genetic associations with human longevity at the APOE and ACE loci Nat. Genet. 6 1994 29 32
165. C. Qiu, M. Kivipelto, H. Agüero-Torres, B. Winblad, and L. Fratiglioni Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex, Journal of Neurology Neurosurg. Psychiatry 75 2004 828 833
166. L. Rosvall, D. Rizzuto, H.X. Wang, B. Winblad, C. Graff, and L. Fratiglioni APOE-related mortality: effect of dementia, cardiovascular disease and gender Neurobiol. Aging 30 2009 1545 1551
167. D.G. Kuhel, E.S. Konaniah, J.E. Basford, C. McVey, C.T. Goodin, T.K. Chatterjee, N.L. Weintraub, and D.Y. Hui Apolipoprotein E2 accentuates postprandial inflammation and diet-induced obesity to promote hyperinsulinemia in mice Diabetes 62 2013 382 391
168. B. Satirapoj, O. Supasyndh, R. Dispan, D. Punpanich, S. Tribanyatkul, and P. Choovichian Apolipoprotein E genetic polymorphisms and the development of nephropathy in type 2 diabetes J. Med. Assoc. Thai. 96 2013 1119 1126
169. A. Nebel, R. Kleindorp, A. Caliebe, M. Nothnagel, H. Blanché, O. Junge, M. Wittig, D. Ellinghaus, F. Flachsbart, and H.-E. Wichmann A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals Mech. Ageing Dev. 132 2011 324 330
170. D. Galinsky, C. Tysoe, C.E. Brayne, D.F. Easton, F.A. Huppert, T.R. Dening, E.S. Paykel, and D.C. Rubinsztein Analysis of the apo E/apo CI, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity Atherosclerosis 129 1997 177 183
171. J.C. Morris, S. Weintraub, H.C. Chui, J. Cummings, C. DeCarli, S. Ferris, N.L. Foster, D. Galasko, N. Graff-Radford, and E.R. Peskind The uniform data set (UDS): clinical and cognitive variables and descriptive data from alzheimer disease centers Alzheimer Dis. Assoc. Disorders 20 2006 210 216
172. D.L. Beekly, E.M. Ramos, W.W. Lee, W.D. Deitrich, M.E. Jacka, J. Wu, J.L. Hubbard, T.D. Koepsell, J.C. Morris, and W.A. Kukull The National Alzheimer's Coordinating Center (NACC) database: the uniform data set Alzheimer Dis. Assoc. Disorders 21 2007 249 258
173. E. De Marinis, C. Martini, A. Trentalance, and V. Pallottini Sex differences in hepatic regulation of cholesterol homeostasis J. Endocrinol. 198 2008 635 643
174. H. Brussaard, J.G. Leuven, M. Frölich, C. Kluft, and H. Krans Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM Diabetologia 40 1997 843 849
175. L. Kaerst, A. Kuhlmann, D. Wedekind, K. Stoeck, P. Lange, and I. Zerr Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis J. Neurol. 260 2013 2722 2727
176. E. Teng, N. Chow, K.S. Hwang, P.M. Thompson, K.H. Gylys, G.M. Cole, C.R. Jack Jr., L.M. Shaw, J.Q. Trojanowski, and H.D. Soares Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort Dement. Geriatr. Cogn. Disord. 39 2015 154 166
177. D. Lehmann, H. Refsum, E. Nurk, D. Warden, G. Tell, S. Vollset, K. Engedal, H. Nygaard, and A. Smith Apolipoprotein E ϵ4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference Hordaland Health Study, J. Neurol., Neurosurg. Psychiatry 77 2006 902 908
178. W.L. DeLano, The Pymol Molecular Graphics System, 2002.